MEGGAN SMITH: Open Payments
NPI 1962043133 · ROBBINSVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$354 in 15 payments from 8 companies in 2025. Trend: 2023 $114 · 2024 $303 · 2025 $354
Food & beverage: $354
| Company | Payments | Amount |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 6 | $193 |
| Novo Nordisk Inc | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| ABBVIE INC. | 1 | $23 |
| Lilly USA, LLC | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Viatris Specialty LLC | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: ADSTILADRIN, Rybelsus, CAPLYTA, BOTOX, Ozempic, MOUNJARO, TRINTELLIX, YUPELRI.
Industry payments across NC — which companies pay providers there.
